Over-testing for heparin induced thrombocytopenia in hospitalized patients

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 1, 2015, Pages 12-16

  Chaturvedi, Shruti ^a   Kohli, Ruhail ^a   McCrae, Keith ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

4T score; Anti Heparin PF4 ELISA; Heparin induced thrombocytopenia; Pre test probability; Screening test; Thrombocytopenia

Indexed keywords

ANTIBODY; HEPARIN; HEPARIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT;

4T SCORE; ARTICLE; ASSAY; CARDIOVASCULAR SURGERY; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED PLATELET AGGREGATION TEST; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; SCREENING TEST; SENSITIVITY ANALYSIS; SEROTONIN RELEASE ASSAY; TERTIARY CARE CENTER; VASCULAR SURGERY; AGED; BLOOD; CHEMICALLY INDUCED; HOSPITALIZATION; MIDDLE AGED; PROCEDURES; STANDARDS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNNECESSARY PROCEDURE;

AGED; ANTICOAGULANTS; FEMALE; HEPARIN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOCYTOPENIA; UNNECESSARY PROCEDURES;

EID: 84948716397     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1123-0     Document Type: Article

References (26)

1. Amiral J, Bridley F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95–96
2. Warkentin TE, Greinacher A (2009) Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opin Drug Saf 8:129–144
3. Teh CH, Robertson MN, Warkentin TE, Henriksen PA, Brackenbury ET, Anderson JA (2010) Transient global amnesia as the presenting feature of heparin-induced thrombocytopenia. J Card Surg 25:300–302
4. Warkentin TE (1996) Heparin induced skin lesions. Br J Haematol 92:494–497
5. Warkentin TE Kelton JG (1996) A 14-year study of heparin-induced thrombocytopenia. Am J Med 101:502–507
6. Greinacher A, Eichler P, Lubenow N, Kwasny H, Luz M (2000) Heparin-induced thrombocytopenia with thromboembolic complications: a meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96:846–851
7. Cuker A, Cines DB (2012) How I treat heparin-induced thrombocytopenia. Blood 119:2209–2218
8. Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB (2008) Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med 168:94–102
9. Smythe MA, Warkentin TE, Woodhouse AL, Zakalik D (2011) Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT “overdiagnosis” in a patient with antiphospholipid syndrome. Am J Hematol 86:188–191
10. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A (2006) Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 4:759–765
11. Lillo-Le Louët A, Boutouyrie P, Alhenc-Gelas M, Le Beller C, Gautier I, Aiach M, Lasne D (2004) Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2:1882–1888
12. Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB (2010) The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 8:2642–2650
13. Nellen V, Sulzer I, Barizzi G, Lammle B, Alberio L (2012) Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients. Haematologica 97:89–97
14. Bryant A, Low J, Austin S, Joseph JE (2008) Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T’s score and particle gel immunoassay. Br J Haematol 143:721–726
15. Pouplard C, Gueret P, Fouassier M, Ternisien C, Trossaert M, Régina S, Gruel Y (2007) Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 5:1373–1379
16. Demma LJ, Winkler AM, Levy JH (2011) A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Anesth Analg 113:697–702
17. Denys B, Stove V, Phillipe J, Devreese K (2008) A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia. Thromb Res 123:137–145
18. Backchoul T, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJ (2009) Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 7:1260–1265
19. Berry C, Tcherniantchouk O, Ley EJ, Salim A, Mirocha J, Martin-Stone S, Stolpner D, Margulies DR (2011) Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients. J Am Coll Surg 213:10–17
20. Crowther MA, Cook DJ, Albert M, Williamson D, Meade M, Granton J, Skrobik Y, Langevin S, Mehta S, Hebert P, Guyatt GH, Geerts W, Rabbat C, Douketis J, Zytaruk N, Sheppard J, Greinacher A, Warkentin TE; Canadian Critical Care Trials Group (2010) The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care 25:287–293
21. Selleng S, Malowsky B, Itterman T, Bagemuhl J, Wessel A, Wollert HG, Warkentin TE, Greinacher A (2010) Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Am J Heart 160:362–369
22. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD (1997) Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95:1242–1246
23. Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, Warkentin TE, Greinacher A (2010) Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost 8:30–36
24. Cuker A, Gimotty PA, Crowther MA, Warkentin TE (2012) Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 120:4160–4167
25. Patrick AR, Winkelmayer WC, Avorn J, Fischer MA (2007) Strategies for the management of suspected heparin-induced thrombocytopenia: a cost effectiveness analysis. Pharmacoeconomics 25:949–961
26. Warkentin TE (2012) HIT: treatment easier, prevention harder. Blood 119:1099–1100